Latest TB Stories
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB NEW
Study led by NYU Langone Medical Center Looks at Calcium Channels as Regulators of Immune Responses to Tuberculosis NEW YORK, May 4, 2015 /PRNewswire-USNewswire/ -- Many of us take
New funding supports the STAND trial and advances other new tools critical for tackling TB in the Asia-Pacific region and around the world NEW YORK, March 24, 2015 /PRNewswire-USNewswire/
March 24 is World Tuberculosis Day HARRISBURG, Pa., March 24, 2015 /PRNewswire-USNewswire/ -- In observance of World Tuberculosis Day, Acting Secretary of Health Dr.
TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years NEW YORK, Feb.
- Assign-bTB Designed to Differentiate TB-Infected Animals from Vaccinated Ones PALMERSTON NORTH, New Zealand, Feb.
HILDEN, Germany and BEIJING, February 11, 2015 /PRNewswire/ -- - China's first population-based study of latent TB infection, published in The
NEW YORK, Jan.
Drug for treating diabetes can double up as adjunct treatment for tuberculosis SINGAPORE, Dec 17, 2014 - (ACN Newswire)
Memorandum of Understanding Signed to Address the Global Health Threat of Antibiotic-Resistant Bacteria NEW BRUNSWICK, N.J., Dec.
- The parings of haberdine; also, any kind of fragments.